$90,000
＋12.5%
Chief Operating Officer
2024
$90k
40 hrs/wk
Chief Operating Officer at Congenital Hyperinsulinism International
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Jennifer Schmitt has been listed as an employee of Congenital Hyperinsulinism International in Form 990 filings since fiscal year 2023. Total compensation for Jennifer Schmitt has increased by 12.5% from 2023 to 2024.